Dates and deadlines

MCP IRB committee meets every 2nd Wednesday of each month from 12:00 PM to 1:00 PM. Per regulations, IRB members must be provided with research materials sufficiently in advance to allow review of the material to prepare for any deliberation and voting. Per local policy, this is generally one week before the meeting. Therefore, the submission deadline is ten (10) business days before each IRB meeting to allow for any changes and to meet the review timeline. Submit materials following the IRB submission checklist and instructions on each applicable form. Below is a schedule of IRB meetings and submission deadlines for Initial, continuing and amendment (modification) applications that involve greater than minimal risk to subjects. Submit all documents via IRBNet. For all IRB submissions, an original signature is not required. The Principal Investigator must sign all packages before they are submitted for IRB review.

*Note: Submissions received on the deadline date must be complete and review ready to be placed on the Agenda for review at next convened board meeting.

Medical City Plano IRB requires all individuals involved in the conduct of human subject research to be appropriately trained prior to conducting human subject research.  In addition, training is required to be renewed every three years while the study is active and under IRB oversight.

If an investigator has not completed initial or renewal of training within the last three years, an initial protocol submission or continuing review will not be approved.

If a researcher listed on the protocol has not completed training, the researcher must complete the training in order to remain on the protocol, or his or her name will be removed from the protocol at the time of approval. If a name is removed it may be added in the form of an amendment at a later date, after training is completed. All researchers must maintain a valid training certification to receive approval for any new or continuing review IRB submission. A valid certification is successful completion of human subject protection and/or good clinical practice course(s) that have been completed within the last three years.

NOTE: If your research involves investigational drugs and/or devices, then Medical City Plano IRB requires all researchers to complete the most recent version of Good Clinical Practice (GCP) for Clinical Trials with Investigational Drugs and Medical Devices for U.S. FDA Focus.

Please refer to IRBNet ‘Forms and Templates’ for training venue options or contact the IRB for guidance or any additional inquiries.